Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance (Q46485766)

22 December 2017

title

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance (English)

1 reference

22 December 2017

1 reference

22 December 2017

Pär Stattin

object named as

Pär Stattin

1 reference

22 December 2017

author name string

Andreas Josefsson

1 reference

22 December 2017

Pernilla Wikström

1 reference

22 December 2017

Torvald Granfors

1 reference

22 December 2017

Lars Karlberg

1 reference

22 December 2017

Anders Bergh

1 reference

22 December 2017

publication date

27 March 2012

1 reference

22 December 2017

Scandinavian Journal of Urology and Nephrology

published in

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

247-257

1 reference

22 December 2017

An updated catalog of prostate cancer predictive tools

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Molecular markers in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Association between integrin expression and prognosis in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Long-term outcome among men with conservatively treated localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

The role of tissue microarrays in prostate cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Endoglin (CD105) as a urinary and serum marker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2012.669791

10.3109/00365599.2012.669791

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

release_utmmn7g6qbdmjiffbq7hej6bwa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/utmmn7g6qbdmjiffbq7hej6bwa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017